Joel Isaacson & Co., LLC
- SEC CIK
- 0001599330
- Latest filing
- Aug 4, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Joel Isaacson & Co., LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,773
- Value
- $433.1K
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,773 | $433.1K | <0.1% | −177−3.6% | Reduced | Holders |
| Q1 2026 | 4,950 | $508.2K | <0.1% | −154−3.0% | Reduced | Holders |
| Q4 2025 | 5,104 | $639.5K | <0.1% | −46−0.9% | Reduced | Holders |
| Q3 2025 | 5,150 | $689.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 5,150 | $700.5K | <0.1% | +1,058+25.9% | Added | Holders |
| Q1 2025 | 4,092 | $542.8K | <0.1% | +88+2.2% | Added | Holders |
| Q4 2024 | 4,004 | $452.9K | <0.1% | +1,957+95.6% | Added | Holders |
| Q3 2024 | 2,047 | $233.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 2,047 | $212.7K | <0.1% | −190−8.5% | Reduced | Holders |
| Q1 2024 | 2,237 | $254.3K | <0.1% | +370+19.8% | Added | Holders |
| Q4 2023 | 1,867 | $205.5K | <0.1% | +1,867 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −1,817−100.0% | Sold out | Holders |
| Q1 2022 | 1,817 | $211.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,817 | $256.0K | <0.1% | −222−10.9% | Reduced | Holders |
| Q3 2021 | 2,039 | $241.0K | <0.1% | +281+16.0% | Added | Holders |
| Q2 2021 | 1,758 | $204.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 1,758 | $211.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.